RG
CTSO icon

Redmile Group’s Cytosorbents Corp CTSO Stock Holding History

Redmile Group’s Portfolio CTSO Stock Details CTSO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-9,082
Closed -$612K – 76
2023
Q1 		$612K Sell
9,082
-4,236
-32% -$254K 0.03% 74
2022
Q4 		$413K Hold
13,318
– – 0.02% 68
2022
Q3 		$362K Hold
13,318
– – 0.01% 70
2022
Q2 		$583K Hold
13,318
– – 0.02% 70
2022
Q1 		$850K Sell
13,318
-22,544
-63% -$1.61M 0.03% 69
2021
Q4 		$3M Sell
35,862
-16,360
-31% -$1.84M 0.07% 67
2021
Q3 		$8.48M Sell
52,222
-12,996
-20% -$2.11M 0.15% 65
2021
Q2 		$9.85M Sell
65,218
-41,164
-39% -$6.94M 0.15% 75
2021
Q1 		$18.5M Buy
106,382
+3,675
+4% +$701K 0.26% 70
2020
Q4 		$16.4M Sell
102,707
-2,350
-2% -$393K 0.2% 67
2020
Q3 		$16.8M Buy
+105,057
New +$19M 0.31% 58

Other funds holding CTSO

SC
Skylands Capital Milwaukee, Wisconsin $814M AUM 32.37% 1-Year Est. Return
AC
Avenir Corporation Alexandria, Virginia $821M AUM 4.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.81B AUM 83.9% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $832M AUM 24.89% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JAMONY
Jacob Asset Management of New York Hermosa Beach, California $70.9M AUM 14.28% 1-Year Est. Return

Redmile Group's CTSO Position: Q2 2023 in Review

Redmile Group sold out of Cytosorbents Corp (CTSO) in Q2 2023, closing a stake of 9,082 shares — an estimated $612K sold.

Redmile Group first reported a position in CTSO in Q3 2020 and held it in 11 quarters. The position peaked at $18.5M in Q1 2021. 57 funds tracked by Wall St. Rank hold CTSO as of Q2 2023.

  • Redmile Group reported no remaining Cytosorbents Corp position as of Q2 2023 after selling out during the quarter.
  • Redmile Group sold 9,082 Cytosorbents Corp shares in Q2 2023, an estimated $612K.
  • Redmile Group first reported a position in Cytosorbents Corp in Q3 2020 and held it in 11 quarters.
  • Redmile Group's Cytosorbents Corp position peaked at $18.5M in Q1 2021.
  • 57 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q2 2023.

Based on Redmile Group's 13F filing for Q2 2023, filed 14 Aug 2023.